Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 10 of 28
-
Russian government issues its first health-related compulsory license
A new year signals a new approach to access to medicines in the Russian Federation. Remdesivir, a drug patented by...
-
New data demonstrates the impact of patents in Ukraine
2020 will be remembered for COVID-19. The scale of the pandemic highlights the urgent need to ensure equitable access to...
-
Natalia: “You only live once (YOLO), make it positive!”
An interview with Natalia, a former team member and friend of 100% LIFE, our campaign partner in Ukraine, and life-long...
-
A Tribute: Dr. Mongkol Na Songkhla – Putting Health Before Trade
We join our partner in Thailand, and activists around the world, to pay tribute to Dr. Mongkol Na Songkhla, a...
-
Thailand submits patent opposition on TB drug for children
Johnson & Johnson’s TB drug, bedaquiline (BDQ) can improve lives. The pediatric version is not substantially different to the adult...
-
“Training the next generation of treatment activists in Central America”
“Only around half of people living with HIV across Central America have access to life-saving treatment. The picture when it...
-
Vietnam’s route to optimal, affordable HIV treatment
Following civil society advice, Vietnam’s Ministry of Health recommended TLD for HIV treatment. This was back in November 2019. Vietnam...
-
OPINION: Breaking a ‘vicious cycle’ of overpaying for HIV drugs in Ukraine
“In November 2020, Ukraine finally shifted from the overpriced branded version of darunavir (DRV) to the more affordable generic version of...
-
HIV activists are essential to the COVID-19 response
The legacy of HIV activism is approaching a 40-year history, one which is inextricably linked with the actions of pharmaceutical...
-
COVID-19 vaccine announcements: Our view
Following on from the BioNTech and Pfizer vaccine announcement earlier this month, where we expressed cautious optimism, but also the...
-
Who will get Pfizer’s COVID-19 vaccine?
BioNTech and Pfizer have announced today that their vaccine candidate has, so far, been found to be more than 90%...
-
Russian government advised – “issue compulsory license to make generic COVID-19 drug available”
First civil society, and now a generic drug company, have asked the Russian government to issue a compulsory license on...
